FMP

FMP

Enter

XBIO - Xenetic Biosciences,...

Valuation of Xenetic Biosciences, Inc.(XBIO), Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized c

photo-url-https://financialmodelingprep.com/image-stock/XBIO.png

Xenetic Biosciences, Inc.

XBIO

NASDAQ

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

3.99 USD

-0.19 (-4.76%)

Valuation Date:

Jun 18, 2024 4:00 PM

Share Price on Valuation Date

$3.99

Stock Beta

2.382

Shares Outstanding

1540680

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep